MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income - PACIRA PHARMACEUTICALS INC ownership

PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 261 filers reported holding PACIRA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.51 and the average weighting 0.2%.

Quarter-by-quarter ownership
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income ownership history of PACIRA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$8,216,000
-48.3%
140,927
-32.3%
1.05%
-40.3%
Q1 2022$15,890,000
+26.8%
208,197
-0.0%
1.76%
+27.5%
Q4 2021$12,530,000
+6.1%
208,242
-1.2%
1.38%
+1.0%
Q3 2021$11,809,000
-8.3%
210,877
-0.6%
1.37%
-5.0%
Q2 2021$12,871,000
+52.7%
212,112
+76.4%
1.44%
+47.1%
Q1 2021$8,427,000
-2.4%
120,232
-16.6%
0.98%
-15.3%
Q4 2020$8,631,000
+11.7%
144,227
+12.2%
1.16%
-12.0%
Q3 2020$7,726,000
+17.2%
128,502
+2.3%
1.31%
+9.2%
Q2 2020$6,593,000
+31.1%
125,657
-16.2%
1.20%
+0.3%
Q1 2020$5,029,000
+8.4%
149,992
+46.5%
1.20%
+66.5%
Q4 2019$4,639,000
+0.3%
102,411
-15.7%
0.72%
-5.9%
Q3 2019$4,624,000
-3.0%
121,466
+10.8%
0.76%
+3.7%
Q2 2019$4,767,000
+39.3%
109,611
+21.9%
0.74%
+39.8%
Q1 2019$3,422,000
-48.6%
89,921
-41.9%
0.53%
-41.0%
Q4 2018$6,657,000
-27.2%
154,736
-16.8%
0.90%
+8.0%
Q3 2018$9,140,000
+19.0%
185,906
-22.4%
0.83%
+17.3%
Q2 2018$7,681,000
-19.6%
239,641
-21.9%
0.71%
-24.6%
Q1 2018$9,555,000
-49.0%
306,786
-25.3%
0.94%
-29.2%
Q4 2017$18,742,000
+27.7%
410,561
+5.1%
1.32%
+37.2%
Q3 2017$14,671,000390,6850.97%
Other shareholders
PACIRA PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Gagnon Advisors, LLC 251,140$19,167,0008.83%
GAGNON SECURITIES LLC 610,933$46,626,0007.60%
Tamarack Advisers, LP 205,000$15,646,0007.40%
Spyglass Capital Management LLC 1,871,040$142,798,0004.88%
Lisanti Capital Growth, LLC 302,413$23,080,0002.59%
Rock Springs Capital Management LP 1,000,000$76,320,0001.92%
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income 208,197$15,890,0001.76%
JABODON PT CO 49,052$3,744,0001.70%
Zweig-DiMenna Associates LLC 166,675$12,721,0001.70%
NEUMEIER POMA INVESTMENT COUNSEL LLC 317,425$24,226,0001.63%
View complete list of PACIRA PHARMACEUTICALS INC shareholders